StockData
Aclarion, Inc. logo

Aclarion, Inc. (ACON) income statement

ACONNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACONW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$1.34−0.03 (-2.19%)

Close on Nov 18, 2026Market cap $3.86MP/E –Yield –

Aclarion, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
21.8%
Operating margin
-11592.1%
Net margin
-10978.5%
Return on equity, FY2025
-104.8%

Financial strength

Current ratio
16.20
Debt to equity
–
Debt to assets
–
Cash to current liabilities
1570.5%

Valuation

P/E ratio
–
Price to sales
46.11
Price to book
0.23
Dividend yield
–

See a number that looks wrong?